Canine Lymphoma Diagnostics Past, Present and Future: How AI technology and genetics are pushing the boundaries in veterinary medicine

October 12, 2023

‍Presentation Detail

‍Speaker
Rachel Venable, DVM, MS, DACVIM (Oncology)

Presentation Date
Oct 12, 2023 at 12pm

Venue
Peppermill Resort, Reno, Nevada

Synopsis
Dr. Rachel Venable presents a comprehensive overview of methods used to diagnose canine lymphoma. She introduces flow cytometry and provides a summary of its use in lymphoma diagnosis and subtype determination. Dr. Venable will also share insights on how to use information from flow cytometry to develop treatment plans, and describe the use of other tests such as immunohistochemistry and molecular diagnostics.

‍

Presentations

Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions

Veterinary Cancer Society Annual Conference 2023

Canine Lymphoma Diagnostics Past, Present and Future: How AI technology and genetics are pushing the boundaries in veterinary medicine

‍Presentation Detail

Presentations

Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions

Impact of AI on clinical practice and outcome

Identification of drug response biomarkers for canine lymphoma in large-scale NGS screen

ImpriMed: AI-driven Personalized Medicine for Pet Cancer Care

Reinventing precision medicine: from dogs to humans

Identification of Novel Predictive Biomarkers of Anticancer Drug Responses in Canine B-Cell Lymphoma Using Targeted NGS

ImpriMed Research Update

Drugs predicted to be effective using artificial intelligence (AI) double the clinical response rate in canines with relapsed B-cell lymphoma

ImpriMed Research Update

Precision medicine for pet cancer care

Predicting dynamic clinical outcomes of (L-)CHOP chemotherapy for canine lymphoma patients using an artificial intelligence model

ImpriMed: Experiences from the eyes of an oncologist in clinical practice

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model

ImpriMed: A data-driven, personalized chemotherapy drug testing service for canine blood cancer patients

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test

From dog to human: precision medicine for comparative oncology

ImpriMed: precision medicine for pet cancer care

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test